Microparticles and nanoparticles for drug delivery

2000/01/01 by Daniel S. Kohane, Steluța Marin, Laura González Ginovés +4 · 27 citations
Arts and Humanities · Chemistry · Engineering · Medicine · Pharmacology, Toxicology and Pharmaceutics · #Advanced Drug Delivery Systems #Archaeological and Geological Studies #Archaeological and Historical Studies #Biochemical engineering #Chemistry #Chromatography #Drug #Drug Solubulity and Delivery Systems #Drug carrier #Drug delivery #Engineering #Inhalation and Respiratory Drug Delivery #Materials science #Medicine #Medieval Architecture and Archaeology #Nanoparticle #Nanotechnology #Pharmaceutical technology #Pharmaceutics #Pharmacology #Targeted drug delivery

paper · pdf · doi:10.1002/bit.21301

openalex publication_date 2006/12/26 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/01

Abstract

Particulate drug delivery systems have become important in experimental pharmaceutics and clinical medicine. The distinction is often made between micro- and nanoparticles, being particles with dimensions best described in micrometers and nanometers respectively. That size difference entails real differences at many levels, from formulation to in vivo usage. Here I will discuss those differences and provide examples of applications, for local and systemic drug delivery. I will outline a number of challenges of interest in particulate drug delivery.

Cited by

• Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses
• Synthetic Ligand-Coated Magnetic Nanoparticles for Microfluidic Bacterial Separation from Blood
• Nanovehicular intracellular delivery systems. [europepmc]
• Delivery of rapamycin to dendritic cells using degradable microparticles. [europepmc]
• Physical approaches to biomaterial design. [europepmc]
• Controlling silk fibroin particle features for drug delivery. [europepmc]
• Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. [europepmc]
• Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. [europepmc]
• Biomimetic delivery with micro- and nanoparticles. [europepmc]
• Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. [europepmc]
• Drug delivery systems: Advanced technologies potentially applicable in personalized treatments. [europepmc]
• Effects of microparticle size and Fc density on macrophage phagocytosis. [europepmc]
• Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres. [europepmc]
• "The Good, the Bad and the Ugly" of Chitosans. [europepmc]
• Drug delivery systems for prolonged duration local anesthesia. [europepmc]
• Ultrasound-triggered local anaesthesia. [europepmc]
• A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination. [europepmc]
• Creation of a long-acting nanoformulated dolutegravir. [europepmc]
• Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses. [europepmc]
• Investigation of tunable acetalated dextran microparticle platform to optimize M2e-based influenza vaccine efficacy. [europepmc]
• Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists. [europepmc]
• Recent advances in nanotherapeutic strategies for spinal cord injury repair. [europepmc]
• Nanomodulation of Macrophages in Multiple Sclerosis. [europepmc]
• Emerging Applications of Drug Delivery Systems in Oral Infectious Diseases Prevention and Treatment. [europepmc]
• Exposure to air pollutants and the gut microbiota: a potential link between exposure, obesity, and type 2 diabetes. [europepmc]
• Microfluidic formulation of nanoparticles for biomedical applications. [europepmc]
• Pharmaceutical nanotechnology: from the bench to the market. [europepmc]

Related

• Insights of Nanoemulsion as a Drug Delivery System: An Overview of Current Trends and Applications
• Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles’ Physicochemical Properties on Responses in Biological Systems
• Controlled Drug Delivery Systems: Current Status and Future Directions
• Enhancement of the solubility, bioavailability and absorption of poorly soluble drug candidates through nanotechnology- a review.
• Nano drugs in modern Drug delivery : "advances , application and economic challenges"